- Home
- ACHR vs PLSE Comparison
ACHR vs PLSE Comparison
Compare ACHR & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACHR | PLSE |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.6B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ACHR | PLSE |
|---|---|---|
| Price | $5.51 | $53.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | $12.00 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 31.1M | 491.4K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.28 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $300,000.00 | N/A |
| Revenue This Year | $4,986.67 | $840.00 |
| Revenue Next Year | $876.87 | $287.54 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.30 | $12.56 |
| 52 Week High | $14.62 | $55.37 |
Technical Indicators
Market Signals| Indicator | ACHR | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 46.19 | 67.27 |
| Support Level | $5.51 | $24.27 |
| Resistance Level | $5.59 | N/A |
| Average True Range (ATR) | 0.25 | 3.51 |
| MACD | -0.08 | -0.20 |
| Stochastic Oscillator | 10.05 | 64.41 |
Price Performance
Historical ComparisonAbout ACHR Archer Aviation Inc.
Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks. It is creating an electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner. The company is building a platform to deliver aircraft, technologies, and services to customers world-wide across commercial and defense sectors.
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.